Use of step therapy protocols prohibition for the treatment of neurological conditions
Author added
Email me when SF 5187 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track SF 5187. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill bars health insurers from forcing patients with neurological disorders to follow step‑therapy protocols when a prescribed drug is FDA‑approved and listed on the plan’s formulary. It applies only when the drug’s use matches its FDA indication and a clinical practice guideline. The rule takes effect on Jan. 1, 2027 for plans issued or renewed after that date.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about SF 5187
3 free questions a day, no accountHistory
- Author added Boldon
- Referred to Commerce and Consumer Protection
- Introduction and first reading
Sponsors
- Mann · sponsor
- Boldon
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when SF 5187 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track SF 5187 freeOr ask your AI assistant about SF 5187 directly:
Add to Claude, ChatGPT or Cursor